• NEBANNER

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile

Description:

CAS no865759-246

Proprietates chemicae: Trelagliptin succinatae intermediae


Product Detail

Product Tags

usus

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile adhibetur pro media succinata Trelagliptin.
Trogliptin succinatum dipeptidylum peptidase Ⅳ (DPP - ) inhibitor evolvit ab Takeda (Takeda Pharmaceutical Co, Ltd.) in Iaponia.Potest selective et continue inhibere DPP - et moderari gradum sanguinis GLYCOSA.Fusce probationes ostendunt medicamento salutem et efficaciam bonam habere.Semel in hebdomada efficaciter sanguinem GLYCOSA moderari potest et medicamentum obsequium aegrorum emendare.Mense Maio, 2015, medicamentum ab Iaponia PMDA probatum est ut curatio diabete recenseretur.

Resource-integrated Product Line

wps_doc_0

Testimonium

JIN DUN Medical hasISO absolute et occurrat GMP productionis signapharmacum domesticum et alienum synthesin peritis copiosa experientia ad ducendam societatem R&D.

13
d68590fe
12
111

commoda in Medical Customization

TECHNOL OGY COMMODUS
● Maximum Pressure Catalytic Hydrogenation .High Pressure Hydrogenolysis Reactio.Cryogenic Reactio (<-78%C)
Aromatica Heterocyclica Synthesis
Rearrangement reactionem
Chiral Consilium
● Heck, Suzuki, Negishi, Sonogashira .Gignardus Reactio

JIN DUN R&D

Apparatus

Lab noster varias habet experimentales et tentationes armorum, ut: NMR (Bruker 400M) 、HPLC、chiral-HPLC、LC-MS、LC-MS/MS (API 4000) 、IR、UV、GC、GC-MS, Chromatographia Proin Synthesizer, Parallel Synthesizer, Differentialis ENARRATIO Calorimeter (DSC), Electron Microscopium...

R&D Team

Medicus Jindun coetus professionales R&D habet, et multos peritos domesticos et externos medicamentorum synthesis ad ducendos R&D adhibet, nostram synthesim accuratiorem et efficientem reddit.

wps_doc_3

Causa-Socius

Plures societates pharmaceuticae domesticae supremae adiuverunt, utHansoh, Hengrui et HEC Pharm.Pars eorum hic ostendemus.

wps_doc_4

Customzation Case One:

Cas No.: 110351-94-5

wps_doc_5

Customzation Case Duo:

Cas No.: 144848-24-8

wps_doc_6

Casus Consuetudinis Tres:

Cas No.: 200636-54-0

Cooperatio Modus

1.Customize nova media vel APIs.Eadem quae supra in casu communicantes, clientes postulationes habent pro certis Intermediis vel APIs, et emendas necessarias in foro invenire non possunt, tunc ad Mos adiuvare possumus.

2.Processus Optimization ad Vetus Products.Manipulus noster adiuvabit ad Optimize et meliorem talem productionem cuius via reactionem est vetus, sumptus productio alta est et efficientia humilis est.Plena documenta praebere possumus pro technologia translationis ac processu meliorationis, emptoris auxilio ad efficaciorem productionem.

Ex scutis medicamento ad INDs, JIN DUN Medical te cumunus-subsisto personalized R&D solutiones.

JIN DUN Medicus instat in somniis creandis bigam, productos graves, anxios, severos faciendos, omnesque exitum esse fidelem socium ac amicum clientium!


  • Priora:
  • Deinde:

  • Epistulam tuam hic scribe et mitte nobis